prostate cancer and prostatic diseases سال:2015 - دوره:18

Fa | Ar | En


prostate cancer and prostatic diseases
سال:2015 - دوره:18 - شماره:2

A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers - صفحه:96-103 Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel - صفحه:122-127 Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy - صفحه:182-189 Computed high b -value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer - صفحه:155-160 Erratum: Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases - صفحه:196-196 Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer - صفحه:137-143 Gonadotropin-releasing hormone agonist overuse: urologists’ response to reimbursement and characteristics associated with persistent overuse - صفحه:173-181 Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis - صفحه:110-121 Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort - صفحه:190-195 Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09) - صفحه:167-172 Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images - صفحه:128-136 Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project - صفحه:149-154 Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients - صفحه:144-148 Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system - صفحه:104-109 Re-purposing cryoablation: a combinatorial ‘therapy’ for the destruction of tissue - صفحه:87-95 Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer - صفحه:161-166